Our Products

Products

The current Takeda UK portfolio comprises of the following medicines:

To download a patient information leaflet (PIL) and a summary of product characteristics (SmPC) for each medicine, simply follow the links within the table below:

 

If you are concerned about any of the conditions or treatments listed below please consult your General Practitioner or other healthcare professional. 
Actos® - pioglitazone hydrochloride
Actos 15 mg, 30 mg, 45 mg Tablets SmPC PIL
Adcetris®▼ - brentuximab vedotin  
Adcetris 50 mg powder for concentrate for solution for infusion SmPC PIL
Alofisel®▼ - darvadstrocel *
Alofisel 5 million cells/mL suspension for injection 

SmPC

PIL

Amias® - candesartan cilexetil 
Amias 2 mg, 4 mg, 8 mg, 16 mg, 32 mg Tablets SmPC  PIL 
Amitiza®▼- lubiprostone
Amitiza 24 microgram soft capsules SmPC  PIL
Calcichew® Portfolio - calcium carbonate +/- cholecalciferol
Calcichew 500 mg Chewable Tablets SmPC  PIL 
Calcichew D3 Chewable Tablets SmPC PIL
Calcichew Forte Chewable Tablets SmPC  PIL
Calcichew D3 1000 mg/800 IU Once Daily Chewable Tablets  SmPC  PIL
Calcichew D3 500 mg/400 IU Caplets  SmPC  PIL 
Calcichew D3 Forte Chewable Tablets SmPC  PIL 
Competact® - pioglitazone hydrochloride/metformin hydrochloride
Competact 15 mg/850 mg film-coated Tablets SmPC  PIL
Condyline® - podophyllotoxin
Condyline 0.5% w/v Cutaneous Solution SmPC PIL
Edarbi® - azilsartan medoxomil potassium
Edarbi 20 mg, 40 mg, 80 mg Tablets SmPC  PIL 
Entyvio®▼ - vedolizumab
Entyvio 300 mg powder for concentrate for solution for infusion SmPC PIL 
Instanyl® - fentanyl citrate
Instanyl 50, 100 and 200 mcg nasal spray, solution in single-dose container SmPC  PIL
Instanyl 50, 100 and 200 mcg/dose nasal spray SmPC PIL 
Matrifen® - fentanyl
Matrifen 12, 25, 50, 75, 100 micrograms/hour Transdermal Patch SmPC PIL 
Mepact® - mifamurtide 
Mepact 4 mg powder for suspension for infusion SmPC PIL 
Ninlaro®▼ - ixazomib citrate
Ninlaro 2.3 mg, 3 mg and 4 mg hard capsules SmPC  PIL
Prostap® SR DCS and Prostap®3 DCS - leuprorelin acetate 
Prostap 3 DCS 11.25 mg powder and solvent for 
prolonged-release suspension for injection in pre-filled syringe
SmPC  PIL 
Prostap SR DCS 3.75 mg powder and solvent for 
prolonged-release suspension for injection in pre-filled syringe
SmPC   PIL
Protium® - pantoprazole
Protium 40 mg i.v. powder for solution for injection SmPC PIL
Pantoprazole 20 mg gastro-resistant tablets SmPC PIL
Pantoprazole 40 mg gastro-resistant tablets SmPC PIL
TachoSil® - human fibrinogen, human thrombin 
TachoSil sealant matrix SmPC PIL
Vipdomet®▼ - alogliptin and metformin 

Vipdomet 12.5 mg/850 mg film-coated tablets
Vipdomet 12.5 mg/1000 mg film-coated tablets

SmPC PIL
Vipidia® - alogliptin benzoate
Vipidia 6.25 mg, 12.5 mg, 25 mg film-coated tablets SmPC PIL

 

*Alofisel is marketed by Takeda UK under license from TiGenix

 

 

Please refer to the Summary of Product Characteristics for details on the full side-effect profile and drug interactions of the medicines refered to above. Adverse events should be reported.

Reporting forms and information can be found at https:yellowcard.mhra.gov.uk/ 
Adverse events should also be reported to Takeda UK Ltd on 01628 537900

 

"The black triangle denotes that additional monitoring is required in relation to adverse reactions.  This allows quick identification of new safety information."

 

 

UK/WBC/1707/0002d(2)

Date of Preparation: June 2018